ArticleAmerican journal of clinical dermatology2022

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.

Tiago Torres et al.PubMed ↗Publisher ↗

No numbers read from the abstract.